These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9274977)

  • 21. Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review.
    Agmo A; Galvan A; Heredia A; Morales M
    Psychopharmacology (Berl); 1995 Jul; 120(2):186-94. PubMed ID: 7480551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
    Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
    Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):401-7. PubMed ID: 4153360
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
    Gentili F; Cardinaletti C; Carrieri A; Ghelfi F; Mattioli L; Perfumi M; Vesprini C; Pigini M
    Eur J Pharmacol; 2006 Dec; 553(1-3):73-81. PubMed ID: 17081513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of opioid receptor antagonists on motor-impairing effects of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 2000; 52(3):187-93. PubMed ID: 11055575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
    Abrahao KP; Quadros IM; Souza-Formigoni ML
    Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.
    Boban Blagaic A; Turcic P; Blagaic V; Dubovecak M; Jelovac N; Zemba M; Radic B; Becejac T; Stancic Rokotov D; Sikiric P
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():177-81. PubMed ID: 20388962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between morphine-like analgesics and anticonvulsant drugs.
    Frey HH
    Pharmacol Toxicol; 1987 Mar; 60(3):210-3. PubMed ID: 2884653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking of enhanced sensitivity to behavioral effects of naloxone induced by narcotic agonists in rats.
    Jain R; Ray R
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):407-14. PubMed ID: 15266952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1976 Jul; 198(1):54-65. PubMed ID: 6794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
    Pavlovic ZW; Cooper ML; Bodnar RJ
    Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists.
    Hartmann RJ; Geller I
    Proc West Pharmacol Soc; 1976; 19():243-7. PubMed ID: 11501
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
    Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
    Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.